Advertisement

Topics

4D Molecular Therapeutics Scores $90 Million in Series B Funding

20:00 EDT 4 Sep 2018 | BioSpace

4D Molecular Therapeutics snagged $90 million in a Series B financing round. The company intends to use the funds to advance its Therapeutic Vector Evolution platform and pipeline of next-generation AAV gene therapeutics.

Original Article: 4D Molecular Therapeutics Scores $90 Million in Series B Funding

NEXT ARTICLE

More From BioPortfolio on "4D Molecular Therapeutics Scores $90 Million in Series B Funding"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...